Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway. | J Transl Med | 2024 | 39468621 | PubTator, text mining | PubMed |
| Altered Expressions of IL-15, IFNG, and HPRT1 Genes in the Thin Endometria of Patients with Reproductive Disorders: A Prospective Comparative Study. | J Clin Med | 2024 | 39458137 | PubTator, text mining | PubMed |
| Biological mechanisms of resilience to tau pathology in Alzheimer's disease. | Alzheimers Res Ther | 2024 | 39396028 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals Kawasaki disease susceptibility genes and their association with coronary artery lesion. | Front Pediatr | 2024 | 39318622 | PubTator, text mining | PubMed |
| Altered Expression of C4BPA and CXCL1 Genes in the Endometrium of Patients with Recurrent Implantation Failure after In Vitro Fertilization and Thin Endometrium. | Diagnostics (Basel) | 2024 | 39272751 | PubTator, text mining | PubMed |
| Are cities under bright lights more innovative? Evidence from China. | Heliyon | 2024 | 39253158 | PubTator, text mining | PubMed |
| Elevated hydrostatic pressure disturbs expression of growth factors in human renal epithelial cells. | PLoS One | 2024 | 39240898 | PubTator, text mining | PubMed |
| VEGF-B prevents chronic hyperglycemia-induced retinal vascular leakage by regulating the CDC42-ZO1/VE-cadherin pathway. | FASEB J | 2024 | 39215561 | PubTator, text mining | PubMed |
| Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cells. | Sci Rep | 2024 | 39191829 | PubTator, text mining | PubMed |
| Correction: AAV2-VEGF-B gene therapy failed to induce angiogenesis in ischemic porcine myocardium due to inflammatory responses. | Gene Ther | 2024 | 39187699 | PubTator, text mining | PubMed |
| Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial. | J Am Soc Nephrol | 2024 | 39150859 | PubTator, text mining | PubMed |
| Autocrine VEGF-B signaling maintains lipid synthesis and mitochondrial fitness to support T cell immune responses. | J Clin Invest | 2024 | 39145452 | PubTator, text mining | PubMed |
| Astaxanthin attenuates diabetic kidney injury through upregulation of autophagy in podocytes and pathological crosstalk with mesangial cells. | Ren Fail | 2024 | 39011603 | PubTator, text mining | PubMed |
| Cardiomyocyte crosstalk with endothelium modulates cardiac structure, function, and ischemia-reperfusion injury susceptibility through erythropoietin. | Front Physiol | 2024 | 39011088 | PubTator, text mining | PubMed |
| VEGF-B is involved in diabetic peripheral neuropathy in patients with type 2 diabetes. | Growth Factors | 2024 | 39001597 | PubTator, text mining | PubMed |
| An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1. | PLoS One | 2024 | 38990973 | PubTator, text mining | PubMed |
| Key Regulators of Angiogenesis and Inflammation Are Dysregulated in Patients with Varicose Veins. | Int J Mol Sci | 2024 | 38928491 | PubTator, text mining | PubMed |
| Interleukin-6 as a Director of Immunological Events and Tissue Regenerative Capacity in Hemodialyzed Diabetes Patients. | Med Sci (Basel) | 2024 | 38921685 | PubTator, text mining | PubMed |
| Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer. | Sci Rep | 2024 | 38858458 | PubTator, text mining | PubMed |
| MYLK*FLNB and DOCK1*LAMA2 gene-gene interactions associated with rheumatoid arthritis in the focal adhesion pathway. | Front Genet | 2024 | 38803542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=7